PMC:7035340 / 6319-7077 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"131","span":{"begin":720,"end":723},"obj":"Gene"},{"id":"132","span":{"begin":50,"end":58},"obj":"Species"},{"id":"133","span":{"begin":64,"end":73},"obj":"Species"},{"id":"134","span":{"begin":122,"end":130},"obj":"Species"},{"id":"135","span":{"begin":145,"end":154},"obj":"Species"},{"id":"136","span":{"begin":426,"end":434},"obj":"Species"},{"id":"137","span":{"begin":528,"end":532},"obj":"Chemical"},{"id":"138","span":{"begin":533,"end":539},"obj":"Chemical"},{"id":"139","span":{"begin":552,"end":570},"obj":"Chemical"},{"id":"140","span":{"begin":637,"end":643},"obj":"Chemical"},{"id":"141","span":{"begin":675,"end":681},"obj":"Chemical"},{"id":"142","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"143","span":{"begin":188,"end":209},"obj":"Disease"},{"id":"144","span":{"begin":411,"end":425},"obj":"Disease"},{"id":"145","span":{"begin":440,"end":459},"obj":"Disease"}],"attributes":[{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"Gene:1401"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"Tax:9606"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"Tax:2697049"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:9606"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"Tax:2697049"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"Tax:9606"},{"id":"A138","pred":"tao:has_database_id","subj":"138","obj":"MESH:D010100"},{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"MESH:D010100"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"MESH:D010100"},{"id":"A142","pred":"tao:has_database_id","subj":"142","obj":"MESH:D007239"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"MESH:D007239"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"MESH:D016638"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":552,"end":554},"obj":"Body_part"},{"id":"T7","span":{"begin":702,"end":718},"obj":"Body_part"},{"id":"T8","span":{"begin":714,"end":718},"obj":"Body_part"},{"id":"T9","span":{"begin":735,"end":742},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma284995"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":708,"end":713},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":199,"end":209},"obj":"Disease"},{"id":"T35","span":{"begin":440,"end":459},"obj":"Disease"},{"id":"T36","span":{"begin":450,"end":459},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T18","span":{"begin":75,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T19","span":{"begin":338,"end":339},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T20","span":{"begin":387,"end":388},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T21","span":{"begin":528,"end":532},"obj":"http://purl.obolibrary.org/obo/CLO_0008947"},{"id":"T22","span":{"begin":528,"end":532},"obj":"http://purl.obolibrary.org/obo/CLO_0050140"},{"id":"T23","span":{"begin":628,"end":636},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T24","span":{"begin":628,"end":636},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"},{"id":"T25","span":{"begin":708,"end":713},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T26","span":{"begin":714,"end":718},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T33","span":{"begin":467,"end":482},"obj":"Chemical"},{"id":"T34","span":{"begin":533,"end":539},"obj":"Chemical"},{"id":"T35","span":{"begin":552,"end":554},"obj":"Chemical"},{"id":"T36","span":{"begin":555,"end":570},"obj":"Chemical"},{"id":"T37","span":{"begin":637,"end":643},"obj":"Chemical"},{"id":"T38","span":{"begin":675,"end":681},"obj":"Chemical"},{"id":"T39","span":{"begin":735,"end":742},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_73462"},{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}

{"project":"LitCovid-sentences","denotations":[{"id":"T32","span":{"begin":0,"end":527},"obj":"Sentence"},{"id":"T33","span":{"begin":528,"end":758},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Fig. 1 Corticosteroids treatment for severely ill patients with 2019-nCoV. a Demographics and baseline characteristics of patients infected with 2019-nCoV according to survival condition. aOf the 14 infections, 12 with identified pathogens, 2 diagnosed by characteristic clinical symptoms without identified pathogens; bN = 7. *P \u003c 0.05, a significant difference between the two groups. b Part of indexes of 15 critically ill patients with 2019-nCoV infection during corticosteroids therapy. *P \u003c 0.05 vs. the indexes on day 1. SaO2 oxygen saturation, CS corticosteroids, IMV invasive mechanical ventilation, PaO2/FiO2 ratio of arterial oxygen tension to fractional inspired oxygen concentrations, WBC white blood cell, CRP C-reaction protein, FIB fibrinogen"}